HCA Healthcare, Inc. $HCA Shares Acquired by Resona Asset Management Co. Ltd.

Resona Asset Management Co. Ltd. increased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 1.8% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 63,038 shares of the company’s stock after buying an additional 1,085 shares during the quarter. Resona Asset Management Co. Ltd.’s holdings in HCA Healthcare were worth $24,113,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of HCA. Atlantic Union Bankshares Corp bought a new stake in HCA Healthcare in the 2nd quarter valued at about $48,000. Moors & Cabot Inc. raised its holdings in shares of HCA Healthcare by 4.4% during the second quarter. Moors & Cabot Inc. now owns 896 shares of the company’s stock valued at $343,000 after buying an additional 38 shares during the last quarter. Crestwood Advisors Group LLC bought a new position in HCA Healthcare in the 2nd quarter worth approximately $278,000. Cassaday & Co Wealth Management LLC bought a new stake in HCA Healthcare during the 2nd quarter valued at $270,000. Finally, Huntington National Bank increased its holdings in shares of HCA Healthcare by 6.8% during the second quarter. Huntington National Bank now owns 4,998 shares of the company’s stock valued at $1,915,000 after purchasing an additional 318 shares during the period. Institutional investors own 62.73% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages recently issued reports on HCA. Sanford C. Bernstein reiterated a “market perform” rating and issued a $417.00 target price on shares of HCA Healthcare in a research report on Monday, October 27th. Robert W. Baird raised their price objective on shares of HCA Healthcare from $380.00 to $423.00 and gave the company a “neutral” rating in a research note on Thursday, August 14th. KeyCorp lifted their target price on shares of HCA Healthcare from $465.00 to $475.00 and gave the stock an “overweight” rating in a research report on Monday, October 27th. Mizuho raised their price objective on shares of HCA Healthcare from $475.00 to $505.00 and gave the stock an “outperform” rating in a research note on Monday, October 27th. Finally, UBS Group increased their target price on HCA Healthcare from $495.00 to $525.00 and gave the company a “buy” rating in a report on Monday, October 27th. One analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and ten have given a Hold rating to the stock. Based on data from MarketBeat.com, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus target price of $473.53.

Insider Activity

In related news, EVP Michael R. Mcalevey sold 3,892 shares of the company’s stock in a transaction on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the completion of the transaction, the executive vice president directly owned 3,487 shares in the company, valued at approximately $1,652,105.73. This represents a 52.74% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Michael S. Cuffe sold 3,836 shares of the business’s stock in a transaction on Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the sale, the executive vice president directly owned 31,503 shares in the company, valued at $13,194,716.52. This trade represents a 10.85% decrease in their position. The disclosure for this sale is available in the SEC filing. 1.30% of the stock is currently owned by company insiders.

HCA Healthcare Price Performance

Shares of HCA opened at $471.00 on Friday. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $478.19. The company’s fifty day moving average price is $426.28 and its 200 day moving average price is $390.24. The company has a market capitalization of $107.48 billion, a PE ratio of 18.21, a price-to-earnings-growth ratio of 1.38 and a beta of 1.41.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, October 24th. The company reported $6.96 EPS for the quarter, topping analysts’ consensus estimates of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The business had revenue of $19.16 billion for the quarter, compared to analyst estimates of $18.55 billion. During the same period in the previous year, the company posted $4.90 earnings per share. The firm’s revenue for the quarter was up 9.6% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, December 29th. Shareholders of record on Monday, December 15th will be given a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.6%. The ex-dividend date is Monday, December 15th. HCA Healthcare’s dividend payout ratio (DPR) is currently 11.13%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.